Impact of Next-generation Sequencing (NGS) on Treatment Decisions in the Community Oncology Setting

Dr. Lindsay Overton, poster author and oncology resident from OHSU, Dr. Arthur "Chip" Staddon, Chairman of CCE Board at ASCO with the poster, titled "Impact of Next-generation Sequencing (NGS) on Treatment Decisions in the Community Oncology Setting". View the poster here.